Our FutureFabs will offer solutions to drug companies for outsourced, automated and efficient continuous manufacturing for recombinant proteins using a unique approach that allows for minimal changes to the platform with each new biopharmaceutical project. There are also additional platforms under consideration in area that demand rapid scale up and deployment, such as vaccine manufacturing. In all cases, our platforms seek to fill an industry need for speed to clinic, flexibility, cost efficiency and importantly, easily scalable capacity.
Each 4th Dimension FutureFab will provide a streamlined production line approach using extensive automation, reduced materials and manufacturing footprint and 24/7 operation that can be flexibly employed to meet demand.
In all cases, 4Ds FutureFabs will address:
- Time to Market/Clinic
- Flexibility; Production on demand
- Capital requirements and timing
- Improved control of product quality